1 |
Kole, L., B. Giri, S. K. Manna, B. Pal, and S. Ghosh (2011) Biochanin-A, an isoflavon, showed anti-proliferative and anti-inflammatory activities through the inhibition of iNOS expression, p38-MAPK and ATF-2 phosphorylation and blocking nuclear translocation. Eur. J. Pharmacol. 653: 8-15.
DOI
|
2 |
Moon, Y. J., B. S. Shin, G. An, and M. E. Morris (2008) Biochanin A inhibits breast cancer tumor growth in a murine xenograft model. Pharm. Res. 25: 2158-2163.
DOI
|
3 |
Meinwald, J. (2011) Natural products as molecular messengers. J. Nat. Prod. 74: 305-309.
DOI
|
4 |
Genovese, S. and F. Epifano (2011) Auraptene: a natural biologically active compound with multiple targets. Curr. Drug Targets 12: 381-386.
DOI
|
5 |
Dolinsky, V. W. and J. R. Dyck (2011) Calorie restriction and resveratrol in cardiovascular health and disease. Biochim. Biophys. Acta. 1812: 1477-1489.
DOI
|
6 |
Lee, M. S., C. H. Kim, D. M. Hoang, B. Y. Kim, C. B. sohn, M. R. Kim, and J. S. Ahn (2009) Genistein-derivatives from tetracera scandens stimulate glucose-uptake in L6 myotubes. Biol. Pharm. Bull. 32: 504-508.
DOI
|
7 |
Cartee, G. D. and J. F. Wojtaszewski (2007) Role of Akt substrate of 160 kDa in insulin-stimulated and contraction-stimulated glucose transport. Appl. Physiol. Nutr. Metab. 32: 557-566.
DOI
ScienceOn
|
8 |
Cho, N. and Y. Momose (2008) Peroxisome proliferator-activated receptor gamma agonists as insulin sensitizers: from the discovery to recent progress. Curr. Top Med. Chem. 8: 1483-1507.
DOI
|
9 |
Zou, C., Y. Wang, and Z. Shen (2005) 2-NBDG as a fluorescent indicator for direct glucose uptake measurement. J. Biochem. Biophys. Methods 64: 207-215.
DOI
|
10 |
Lee, M. S., J. T. Hwang, S. H. Kim, S. Yoon, M. S. Kim, H. J. Yang, and D. Y. Kwon (2010) Ginsenoside Rc, an active component of Panax ginseng, stimulates glucose uptake in C2C12 myotubes through an AMPK-dependent mechanism. J. Ethnopharmacol. 127: 771-776.
DOI
|
11 |
Hardie, D. G. (2011) Sensing of energy and nutrients by AMP-activated protein kinase. Am. J. Clin. Nutr. 93: 891S-896S.
DOI
|
12 |
Stolarczyk, M., W. Gutman, and R.A. Derlacz (2011) Nuclear receptors PPAR as a drug target in metabolic disorders. Postepy Biochem. 57:207-14.
|
13 |
Wong, A. K., J. Howie, J. R. Petrie, and C. C. Lang (2009) AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clin. Sci (Lond). 116: 607-620.
DOI
|